Evidence map›Paper›PMID 37163502›Full record

ArticlePloS one2023

Protocol of a scoping review of systematic reviews and meta-analyses about COVID-19 vaccines and associated adverse events from vaccination.

Shelly Melissa Pranić, Lenny T Vasanthan, Jacqueline Y Thompson, Vinayak Mishra, Pratyush Kumar, Roshan Arjun Ananda, Narges Malih, Ka-King Chan

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 51% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 7 institutions in 7 countries.

Shelly Melissa PranićDepartment of Public Health, University of Split School of Medicine, Split, Croatia.ORCID 0000-0001-5524-1723
Lenny T VasanthanDepartment of Physical Medicine and Rehabilitation, Christian Medical College, Vellore, India.
Jacqueline Y ThompsonInstitute of Applied Health Research, University of Birmingham, University of Birmingham, Birmingham, United Kingdom.
Vinayak MishraDepartment of Children's Health, University of Liverpool, Liverpool, United Kingdom.
Pratyush KumarBaba Saheb Ambedkar Medical College, New Delhi, India.
Roshan Arjun AnandaQueensland Health, Queensland, Australia.
Narges MalihGlobal Health Research Group, University of the Balearic Islands (UIB), Palma, Spain.
Ka-King ChanPamela Youde Nethersole Eastern Hospital, Hong Kong, China.ORCID 0000-0002-3669-9138
Christian Medical College, Vellore · INPamela Youde Nethersole Eastern Hospital · CNQueensland Health · AUUniversitat de les Illes Balears · ESUniversity of Birmingham · GBUniversity of Liverpool · GBUniversity of Split · HR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The continuous dissemination of coronavirus disease of 2019 (COVID-19) literature can inform decision-makers and the public. Since the widespread use of COVID-19 vaccines, more systematic reviews have summarized the effectiveness and reported adverse events associated with vaccination. Previous systematic and scoping reviews on COVID-19 summarized various aspects surrounding COVID-19, however, a scoping review is needed to summarize the characteristics of COVID-19 vaccines and associated adverse events reported in systematic reviews and meta-analyses to provide comprehensive evidence for informed medical decision-making. We will conduct a scoping review concerning COVID-19 vaccines and adverse events from vaccines. We will search from December 2019 to present in Epistemonikos, Campbell Library, CINAHL (Ovid), MEDLINE (Ovid), Scopus, CENTRAL (Ovid), Web of Science, WHO COVID-19 database, Joanna Briggs Institute of Excellence, and COVID-19 Evidence Reviews resource. We will include systematic reviews, meta-analyses, or both of randomized controlled trials and observational studies and exclude individual randomized controlled trials and observational studies. Abstracts and full-texts will be screened prior to selection. Investigators will independently use a calibrated quantitative and qualitative data extraction sheet and rate the quality of articles with AMSTAR, resolving disagreements to aim for good agreement (≥80%). An updated scoping review of the characteristics and safety of COVID-19 vaccines would highlight the accuracy of the evidence to inform decision-making concerning COVID-19 vaccination.

Indexed as

COVID-19COVID-19 VaccinesVaccinationData ManagementHumansMeta-Analysis as TopicScoping Reviews as TopicSystematic Reviews as TopicCOVID-19 Vaccines

Identifiers

PMID37163502
PMCPMC10171674
OpenAlexW4376131765

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.